El Paso, NM
Ketamine Therapy clinics in El Paso
Ketamine therapy in El Paso is delivered through psychiatry-led clinics, anesthesia-run infusion centers, and ketamine-assisted psychotherapy practices, with hospital referrals often tied to Texas Tech Physicians and University Medical Center of El Paso. Demand reflects a border, Hispanic-majority, Medicaid-heavy population and an active local market for treatment-resistant depression, PTSD, and chronic pain.
The strongest evidence supports intranasal esketamine (Spravato, FDA-approved for treatment-resistant depression) and intravenous racemic ketamine (off-label, substantial supporting evidence). Clinics in El Paso, Texas also offer intramuscular, sublingual, and at-home oral lozenge protocols, with weaker evidence and variable safety oversight. Texas Medical Board and cross-border pharmacy considerations shapes which clinics can operate as cash-pay versus insurance-eligible.
With ketamine clinics on Regenerated.com in El Paso, patients can compare whether the clinic offers psychiatric evaluation, anesthesia monitoring during infusion, and structured preparation and integration.
Agape Pain Management and Anesthesia
- PRP Therapy
- Ketamine Therapy
- Arthritis Treatment
- Migraine Treatment
- Stem Cell Therapy
Regulatory context
A note on New Mexico's ketamine therapy rules.
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
-
Medical Psilocybin Act / SB 219 (2025)
Signed April 2025, establishing a state medical psilocybin program for qualifying conditions (treatment-resistant depression, PTSD, substance use disorder, end-of-life care); implementation rulemaking underway through the NM Department of Health. -
New Mexico Controlled Substances Act
Mirrors federal scheduling outside the medical psilocybin program.
New Mexico enforces federal scheduling outside the medical psilocybin program. The New Mexico Medical Board oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. The Medical Psilocybin Act requires rulemaking by the New Mexico Department of Health and creates a state-licensed medical program with physician oversight distinct from Oregon's facilitator model and Colorado's healing center model.
Ketamine Therapy in El Paso, answered.
Explore related care